The Patent Finder

Octahydro Fused Azadecalin Glucocorticoid Receptor Modulators

Corcept Therapeutics Incorporated

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 61/985,035, filed Apr 28, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 10,047,082Octahydro Fused Azadecalin Glucocorticoid Receptor Modulators
In force
 · High confidence
UsedRemaining
Corcept Therapeutics, Inc.In forceHigh confidence
US 10,323,034Octahydro Fused Azadecalin Glucocorticoid Receptor Modulators
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
US 10,787,449Octahydro Fused Azadecalin Glucocorticoid Receptor Modulators
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
US 11,560,379Octahydro Fused Azadecalin Glucocorticoid Receptor Modulators
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
US 12,139,486Octahydro Fused Azadecalin Glucocorticoid Receptor Modulators
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
US 11,370,789Octahydro Fused Azadecalin Glucocorticoid Receptor Modulators
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
Application 18/906,346Octahydro Fused Azadecalin Glucocorticoid Receptor Modulators
Pending
Not granted
Corcept Therapeutics, Inc.PendingNot granted
Application 16/036,001Octahydro Fused Azadecalin Glucocorticoid Receptor Modulators
Abandoned
Abandoned Jul 7, 2020
Corcept Therapeutics, Inc.AbandonedAbandoned Jul 7, 2020
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Corcept Therapeutics Incorporated.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited